---
figid: PMC7656306__ijms-21-07768-g001
figlink: pmc/articles/PMC7656306/figure/ijms-21-07768-f001/
number: F1
caption: Mechanism of action of non-oncological drugs in ovarian cancer (OC). Statins
  inhibit 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) leading to the blocking
  of cholesterol biosynthetic pathway though a mevalonate-dependent mechanism. Moreover,
  statins can block drug efflux pumps by a mevalonate-independent mechanism. Bisphosphonates
  block farnesyl pyrophosphate synthase, located downstream HMGCR, leading to the
  impairment of cholesterol biosynthesis. Metformin inhibits insulin signals and glucose
  synthesis via respiratory-chain complex I blockage. Ritonavir is a protease inhibitor
  that inhibits the production of phosphorylated protein kinase B (AKT) leading to
  the impairment of phosphatidylinositol 3-kinases (PI3K)-Akt pathway. Itraconazole
  can inhibit Hedgehog, mammalian target of rapamycin (mTOR), and Wnt signalling pathway.
  Moreover, itraconazole can inhibit angiogenesis and lymphangiogenesis, and promote
  the overexpression of P-glycoprotein. Ivermectin interferes with several cellular
  mechanisms, including multidrug resistance proteins (MDR) inhibition, Akt/mTOR,
  and Wnt signalling pathways modulation, p21–activated kinase (PAK-1) and yes-associated
  protein 1 (YAP1). Moreover, ivermectin promotes the increase of intracellular reactive
  oxygen species (ROS) levels leading to the downregulation of stemness genes. Adenosine
  diphosphate (ADP); adenosine monophosphate (AMP); adenosine triphosphate (ATP);
  3-Hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA).
pmcid: PMC7656306
papertitle: Recycling the Purpose of Old Drugs to Treat Ovarian Cancer.
reftext: Mariana Nunes, et al. Int J Mol Sci. 2020 Oct;21(20):7768.
pmc_ranked_result_index: '1086'
pathway_score: 0.9645811
filename: ijms-21-07768-g001.jpg
figtitle: Action of non-oncological drugs in ovarian cancer (OC)
year: '2020'
organisms:
- Mus musculus
- Human immunodeficiency virus 1
- Rat sarcoma virus
- Pediculus humanus
- Human immunodeficiency virus
- Streptomyces avermitilis
- Human gammaherpesvirus 8
- Homo sapiens
- Canis lupus familiaris
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7656306__ijms-21-07768-g001.html
  '@type': Dataset
  description: Mechanism of action of non-oncological drugs in ovarian cancer (OC).
    Statins inhibit 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) leading
    to the blocking of cholesterol biosynthetic pathway though a mevalonate-dependent
    mechanism. Moreover, statins can block drug efflux pumps by a mevalonate-independent
    mechanism. Bisphosphonates block farnesyl pyrophosphate synthase, located downstream
    HMGCR, leading to the impairment of cholesterol biosynthesis. Metformin inhibits
    insulin signals and glucose synthesis via respiratory-chain complex I blockage.
    Ritonavir is a protease inhibitor that inhibits the production of phosphorylated
    protein kinase B (AKT) leading to the impairment of phosphatidylinositol 3-kinases
    (PI3K)-Akt pathway. Itraconazole can inhibit Hedgehog, mammalian target of rapamycin
    (mTOR), and Wnt signalling pathway. Moreover, itraconazole can inhibit angiogenesis
    and lymphangiogenesis, and promote the overexpression of P-glycoprotein. Ivermectin
    interferes with several cellular mechanisms, including multidrug resistance proteins
    (MDR) inhibition, Akt/mTOR, and Wnt signalling pathways modulation, p21–activated
    kinase (PAK-1) and yes-associated protein 1 (YAP1). Moreover, ivermectin promotes
    the increase of intracellular reactive oxygen species (ROS) levels leading to
    the downregulation of stemness genes. Adenosine diphosphate (ADP); adenosine monophosphate
    (AMP); adenosine triphosphate (ATP); 3-Hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT2
  - AKT3
  - AKT1
  - WNT1
  - WNT5A
  - WNT6
  - WNT7A
  - WNT8A
  - WNT8B
  - WNT10B
  - WNT2B
  - WNT16
  - WNT2
  - WNT3
  - WNT7B
  - WNT11
  - WNT9A
  - WNT9B
  - WNT4
  - WNT10A
  - WNT5B
  - WNT3A
  - ENG
  - MFAP1
  - WDTC1
  - PRKAG2
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG3
  - MTOR
  - SHH
  - IHH
  - DHH
  - Mevalonate
  - Geranyl Pyrophosphate
  - Geranylgeranyl
  - pyrophosphate
  - Farnesyl Pyrophosphate
  - Cholesterol
  - ATP
  - AMP
  - ADP
  - Glucose
  - ITRACONAZOLE
  - tumour
  - Glucose synthesis
genes:
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: end
  symbol: END
  source: hgnc_alias_symbol
  hgnc_symbol: ENG
  entrez: '2022'
- word: AMP/ADP
  symbol: AMP
  source: hgnc_alias_symbol
  hgnc_symbol: MFAP1
  entrez: '4236'
- word: AMP/ADP
  symbol: ADP
  source: hgnc_alias_symbol
  hgnc_symbol: WDTC1
  entrez: '23038'
- word: '*AMPKATP+AMP/ADP'
  symbol: ADP
  source: hgnc_alias_symbol
  hgnc_symbol: WDTC1
  entrez: '23038'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: Hedgehog
  symbol: Hedgehog
  source: bioentities_symbol
  hgnc_symbol: SHH
  entrez: '6469'
- word: Hedgehog
  symbol: Hedgehog
  source: bioentities_symbol
  hgnc_symbol: IHH
  entrez: '3549'
- word: Hedgehog
  symbol: Hedgehog
  source: bioentities_symbol
  hgnc_symbol: DHH
  entrez: '50846'
chemicals:
- word: Mevalonate
  source: MESH
  identifier: D008798
- word: Geranyl Pyrophosphate
  source: MESH
  identifier: C015234
- word: Geranylgeranyl
  source: MESH
  identifier: C002963
- word: pyrophosphate
  source: MESH
  identifier: D011756
- word: Farnesyl Pyrophosphate
  source: MESH
  identifier: C004808
- word: Cholesterol
  source: MESH
  identifier: D002784
- word: ATP
  source: MESH
  identifier: D000255
- word: AMP
  source: MESH
  identifier: D000249
- word: ADP
  source: MESH
  identifier: D000244
- word: Glucose
  source: MESH
  identifier: D005947
- word: ITRACONAZOLE
  source: MESH
  identifier: D017964
diseases:
- word: tumour
  source: MESH
  identifier: D009369
- word: Glucose synthesis
  source: MESH
  identifier: D018149
figid_alias: PMC7656306__F1
redirect_from: /figures/PMC7656306__F1
figtype: Figure
---
